0
Correspondence |

Soluble Triggering Receptor Expressed on Myeloid Cells 1 and the Diagnosis of Ventilator-Associated Pneumonia FREE TO VIEW

Sebastien Gibot, MD
Author and Funding Information

Centre Hospitalier Universitaire Nancy Nancy, France

Correspondence to: Sebastien Gibot, MD, Service de Reanimation Medicale, Hopital Central, CHU Nancy, Nancy 54000, France; e-mail: s.gibot@chu-nancy.fr


The author has no conflict of interest to declare.

Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal.org/site/misc/reprints.xhtml).


© 2009 American College of Chest Physicians


Chest. 2009;136(1):320. doi:10.1378/chest.08-2461
Text Size: A A A
Published online

To the Editor:

We read with interest the report of Marin Kollef and coworkers1 on the usefulness of BAL soluble triggering receptor expressed on myeloid cells 1 (TREM-1) determination in diagnosing ventilator-associated pneumonia. We would like to warn the readers against an important methodologic aspect of the presented work: the authors used a commercially available assay, namely the TREM-1 Quantikine assay (R&D Systems; Minneapolis, MN), to measure soluble TREM-1 concentrations. It happens that this assay was recalled by R&D Systems during the early 2008 summer, and researchers informed (and even reimbursed) due to its inability to accurately measure soluble TREM-1 concentration. A new assay has just been lunched by this company. We therefore recommend to readers and researchers interested in this field to be very careful in interpreting data, positive or negative, obtained by the use of this very assay, and we would encourage the authors to perform new measurements with a different technique.

We also wanted to underline two fundamental methodologic differences that exist between our study2 and this one: first, we used an original antibody (clone 21C7) developed by Bouchon et al3 different from the one used here; second, and more importantly, our measurements were obtained against a reference curve constructed by using the naturally occurring soluble form of TREM-1 (derived from a cell-free Escherichia coli production system) and not a human Ig Fc-containing chimera. This is clearly not a “battle of experts” but crucial differences readers must keep in mind when interpreting data from different works.

Anand NJ, Zuick S, Klesney-Tait J, et al. Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest. 2009;135:641-647. [PubMed] [CrossRef]
 
Gibot S, Cravoisy A, Levy B, et al. Rapid detection of the soluble form of triggering receptor expressed on myeloid cells-1 (TREM-1) in the diagnosis of pneumonia. N Engl J Med. 2004;350:451-458. [PubMed]
 
Bouchon A, Facchetti F, Weigand MA, et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001;230:1103-1107
 

Figures

Tables

References

Anand NJ, Zuick S, Klesney-Tait J, et al. Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest. 2009;135:641-647. [PubMed] [CrossRef]
 
Gibot S, Cravoisy A, Levy B, et al. Rapid detection of the soluble form of triggering receptor expressed on myeloid cells-1 (TREM-1) in the diagnosis of pneumonia. N Engl J Med. 2004;350:451-458. [PubMed]
 
Bouchon A, Facchetti F, Weigand MA, et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001;230:1103-1107
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543